FDA Adverse Event Injury Summary report: N

ASR UNI FEMORAL IMPL SIZE 46

MDR report key: 3103485 · Received May 9, 2013

Report

Report Number
1818910-2013-04433
Event Type
Injury
Date Received
May 9, 2013
Report Date
January 10, 2012
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
PMA / PMN Number
K040627
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Description of Event or Problem · 1

LITIGATION PAPERS ALLEGE ON OR ABOUT THE LATE SUMMER OR FALL OF 2009 AND THEREAFTER, PATIENT SUFFERED THE FOLLOWING PERSONAL AND ECONOMIC INJURIES AS A RESULT OF THE IMPLANTATION WITH THE ASR HIP IMPLANT: PAIN IN THE BOTTOM OF HER FOOT, ON THE SECOND TOE OF HER RIGHT FOOT, RIGHT KNEE PAIN SWELLING IN HER RIGHT CALF, LOWER LEG AND ANKLE AREA, TIGHTNESS IN ABDUCTOR REGION OF RIGHT LOWER EXTREMITY, TIGHTNESS IN BOTH HIPS, BILATERAL THIGH DISCOMFORT, DECREASED SENSATION ON THE RIGHT BIG TOE MEDIAL ASPECT AND MEDIAL ASPECT OF THE RIGHT FOOT. IT IS ALSO ALLEGED TESTING OF THE BLOOD OF PATIENT COLLETED ON (B)(6) 2010, DEMONSTRATED HIGH CHROMIUM BLOOD LEVELS OF 5.7 NG/ML AND HIGH COBALT BLOOD LEVELS OF 19.6 NG/ML. IT IS FURTHER ALLEGED TESTING OF THE BLOOD OF PATIENT COLLECTED ON (B)(6) 2011, DEMONSTRATED HIGH CHROMIUM BLOOD LEVELS OF 10 NG/ML AND HIGH COBALT BLOOD LEVELS OF 49 NG/ML.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
202883 ASR UNI FEMORAL IMPL SIZE 46 FEMORAL HEAD HIP IMPLANT KWA DEPUY INTERNATIONAL 2775334

Patients

Seq Age Sex Outcome Treatment
1 Other